In a small 2012 study at Northumbria University, twenty healthy adults sat in a room scented with diffused rosemary essential oil and then counted backward by sevens, recalled lists of words, and ran through other quick cognitive drills. Researchers Mark Moss and Lorraine Oliver measured a compound called 1,8-cineole in the volunteers’ blood and found that higher blood levels tracked with faster, more accurate performance on the memory tasks.1 The effect was modest. The implication was not.
It suggested that a smell, on its own, could change how a brain performs in the next ten minutes. Not by suggestion or mood, but through a measurable molecule moving from nose to bloodstream to brain.
What did the rosemary study actually find?
Moss and Oliver’s 2012 paper in Therapeutic Advances in Psychopharmacology tested twenty healthy adults inside a cubicle that had been scented with rosemary essential oil for at least four minutes before each session.1 Volunteers gave blood samples, then completed a standard battery of cognitive tasks: serial subtraction, visual information processing, word recall.
The headline result was a correlation. Participants with higher plasma 1,8-cineole concentrations were significantly faster on speed-of-memory tasks, and accuracy on subtraction tests trended upward as cineole levels rose. The authors were careful in how they framed it. Twenty people is a pilot, not a verdict, and the relationship was correlational rather than causal.
Still, the study did something most aromatherapy research does not. It tied a behavioral effect to a specific blood-borne chemical with a plausible mechanism, rather than waving at “the smell” as if smell alone explained it.
The exposure protocol mattered. Volunteers entered a small cubicle that had already been scented for several minutes, so the aroma was steady rather than a sudden burst. Cognitive testing began only after the room had reached a stable concentration. That detail is easy to skip past, and yet it is probably why the effect showed up at all. A whiff of rosemary on the way past a herb garden is not the same exposure profile as twenty minutes of quiet diffusion before a task that demands focus.
How can a smell reach the brain?
1,8-cineole, sometimes called eucalyptol, is a small, fat-soluble terpene that makes up a sizable share of rosemary’s essential oil. When you breathe rosemary aroma, cineole molecules pass across the thin tissue of the nasal cavity and the lungs into the bloodstream. Because they are lipid-soluble, they can cross the blood-brain barrier without much trouble.
Once in brain tissue, laboratory research suggests cineole can inhibit acetylcholinesterase, the enzyme that breaks down acetylcholine. Acetylcholine is a neurotransmitter heavily involved in attention, working memory, and the consolidation of new information. The drugs prescribed for early Alzheimer’s disease, donepezil and rivastigmine among them, work by inhibiting that same enzyme. The proposed mechanism for rosemary, then, is a much weaker version of what those medications do on purpose.
That is the chain the headlines lean on: aroma to cineole to bloodstream to brain to slightly more available acetylcholine to a small bump in cognitive performance. Each link in the chain has some evidence behind it. The chain as a whole has not been proven end to end in a large human trial. The earlier Moss group paper from 2003, which did not measure blood chemistry, also found that rosemary aroma improved performance on quality-of-memory tasks compared to a no-odor control, while lavender impaired it.2
Is this just a placebo dressed up in a lab coat?
Not entirely, but a placebo response is part of the story and there is no point pretending otherwise.
Smell is uniquely entangled with mood and arousal. A pleasant scent can lift alertness, and alert people score better on attention tests. The 2003 Moss paper tried to control for that by also tracking subjective mood and by comparing rosemary against lavender, which is associated with relaxation. Rosemary improved memory speed without making participants feel particularly different on the mood scales the researchers used, while lavender slowed memory and increased calmness.2 If pure expectancy were driving the rosemary result, you would expect the more famously “energizing” scent to also produce the strongest mood shift. It did not.
The 2012 cineole-blood correlation strengthens the case further, because expectation does not change the concentration of a chemical in your veins.1 A volunteer who happens to absorb more cineole through their nasal passages cannot will themselves to absorb more. Yet the people who absorbed more performed better.
None of this proves rosemary is a cognitive enhancer. It is consistent with a small, real, drug-like effect riding alongside whatever placebo and mood effects also exist.
That kind of finding is unusual in the aroma literature. Plenty of essential-oil studies report mood changes after participants sniff something pleasant, which proves only that pleasant things feel pleasant. The Moss group asked a harder question. They asked whether a specific molecule, present in measurable quantities in human blood, lined up with measurable changes on a stopwatch and a score sheet. The answer was a tentative yes.
What about taking rosemary instead of smelling it?
A 2018 randomized clinical trial out of Iran took a different angle. Pejman Nematolahi and colleagues gave 68 university students either 500 mg of dried rosemary leaf in capsule form or a matched placebo, twice daily for one month, and measured memory, anxiety, depression, and sleep with validated questionnaires.3
The rosemary group showed significant improvements in prospective memory, the kind of memory that lets you remember to send the email at four o’clock, as well as in retrospective memory. Self-reported anxiety and depression scores dropped. Sleep quality moved in the same direction but did not reach statistical significance. The study was modest in size and ran in a relatively narrow population, so the authors framed the findings as preliminary and called for larger trials.
What the Nematolahi trial does add is the suggestion that ingested rosemary, not just inhaled rosemary, may reach the brain in doses that matter. That is consistent with the chemistry. Cineole and the other bioactive compounds in rosemary, including carnosic acid and rosmarinic acid, can be absorbed orally and have shown antioxidant and anti-inflammatory activity in animal and cell studies. Whether those mechanisms add up to clinically meaningful cognition gains in healthy adults remains an open question.
One other detail from the Iranian trial deserves a mention. The mood and anxiety effects landed at roughly the same time as the memory effects, which raises an obvious question: did the students remember more because they felt calmer and slept better, or did they feel calmer because rosemary did something directly to brain chemistry? The trial cannot separate the two. Real life cannot either. A student who is sleeping well, breathing easier, and slightly less anxious is also going to learn faster, and that is fine. The mechanism matters for science. The benefit, if it holds up, matters for the student.
Could it help people with dementia?
This is where the evidence is most exciting and also where caution matters most.
A 2009 Japanese trial published in Psychogeriatrics by Daiki Jimbo and colleagues followed 28 elderly patients, most with Alzheimer’s disease, through a 28-day aromatherapy intervention.4 Participants were exposed to rosemary and lemon oils in the morning, intended to stimulate, and to lavender and orange in the evening, intended to calm. The researchers measured cognitive function with standard scales before, during, and after the trial.
Most patients showed improvement on the cognitive screens during the aromatherapy phase, with the effect strongest in the Alzheimer’s subgroup. The trial had no real control group, no blinding, and a very small sample. The authors said as much, and the paper reads as an invitation to do better-designed work, not as a call to swap medication for an essential oil diffuser.
Several follow-up reviews have noted the same pattern across the broader literature. Rosemary and other aromatic herbs keep showing small, suggestive cognitive signals in older adults, but the trials are small, methodologies vary, and outcomes are not always pre-registered. Anyone living with dementia or caring for someone who is should treat aromatherapy as a possibly soothing adjunct, not as a treatment, and should keep talking to their physician about evidence-based care.
How much rosemary, and how?
The studies use different doses and different delivery methods, which makes practical advice hard to pin down precisely.
For inhalation, the Moss trials used essential oil diffused into a small room or test cubicle, typically four drops on a diffuser pad, with at least a few minutes of exposure before any cognitive task. The 2018 capsule trial used 500 mg of dried leaf twice a day. Brewing fresh or dried rosemary as a tea, common in Mediterranean home medicine, falls somewhere in between in terms of likely dose and is generally regarded as safe in food amounts.
Essential oils are concentrated. Ingesting essential oil rather than the dried herb is not the same thing and is not advised without clinician guidance. Topical application of undiluted essential oil can irritate skin. Pregnant women and people with epilepsy are usually told to be cautious with rosemary essential oil at high doses, because some animal data hint at neurological effects at concentrations far above culinary use.
If you want to try this on a study afternoon, the lowest-risk version is what the studies actually tested: a small amount of essential oil in a diffuser, or a fresh sprig in hot water. Pay attention to whether you actually feel a difference. The point of the research is not that rosemary is magic. The point is that a familiar kitchen herb might do something quietly useful, and that is worth a quiet experiment of your own.
Common questions about rosemary and memory
Does rosemary actually improve memory?
In small studies, rosemary aroma and oral rosemary have been linked with modest gains in memory speed and accuracy. The effect sizes are small, the samples are small, and bigger trials are needed before anyone can call rosemary a proven cognitive enhancer.
What is 1,8-cineole?
It is the main aromatic terpene in rosemary essential oil, also found in eucalyptus. It is fat-soluble, crosses into the bloodstream through the lungs and nasal tissue, and appears to inhibit the enzyme that breaks down acetylcholine, a neurotransmitter important for attention and memory.
Is diffusing rosemary safe?
For most healthy adults, brief diffusion at the levels used in research is considered low risk. People with asthma, pregnant women, very young children, and people with epilepsy should be more cautious and consult a clinician before regular use of essential oils.
Can rosemary replace coffee for focus?
No. Caffeine has a different, much better-studied mechanism, with reliable effects on alertness. Rosemary aroma may offer a small, complementary edge in some studies, but it is not a stimulant in the way coffee is.
Will it help with Alzheimer’s disease?
Early trials, including a 2009 Japanese study, hint at small benefits from rosemary-based aromatherapy in dementia, but the evidence is not strong enough to support it as a treatment. It should be treated as a possibly comforting adjunct, not a substitute for medical care.
The honest takeaway
Rosemary is not going to rewrite a person’s cognitive curve. The studies that exist are small, the effects they find are subtle, and the gap between a lab cubicle and a regular Tuesday is real.
What the evidence does support is something more modest and, in a way, more interesting. A common kitchen herb, used at culinary or near-culinary doses, has shown a measurable, mechanism-plausible link to better short-term cognitive performance in multiple independent groups across two decades of research. That is more than can be said for most things sold as brain-boosters. If you like the smell and you have a diffuser, the experiment costs almost nothing. Just hold the claims loosely while you run it.
Sources
- Moss M, Oliver L. Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma. Therapeutic Advances in Psychopharmacology, 2012;2(3):103–13. PubMed: 23983963
- Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. International Journal of Neuroscience, 2003;113(1):15–38. PubMed: 12690999
- Nematolahi P, Mehrabani M, Karami-Mohajeri S, Dabaghzadeh F. Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. Complementary Therapies in Clinical Practice, 2018;30:24–28. PubMed: 28338805
- Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics, 2009;9(4):173–179. PubMed: 20377818
